A detailed history of Groupama Asset Managment transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Groupama Asset Managment holds 6,794 shares of JAZZ stock, worth $835,458. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,794
Previous 6,485 4.76%
Holding current value
$835,458
Previous $692 Million 12.2%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$100.57 - $116.37 $31,076 - $35,958
309 Added 4.76%
6,794 $608 Million
Q2 2024

Aug 14, 2024

SELL
$103.94 - $118.98 $126,494 - $144,798
-1,217 Reduced 15.8%
6,485 $692 Million
Q1 2024

May 14, 2024

SELL
$115.19 - $132.77 $6.78 Million - $7.81 Million
-58,858 Reduced 88.43%
7,702 $933 Million
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $7.61 Million - $9.05 Million
66,560 New
66,560 $8.19 Billion

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.